SMARCA2 and neoplasm: However, interestingly, the NETs density (% area covered by NETs) distribution data (Figure 5A(iii)) showed that, whereas no significant difference existed in the tumor-contacted NETs density between untreated and AZD5069 treated neutrophils within our concentration range (0–10 μM), the BrM-induced stromal NETs diminished significantly (p < 0.001) with an increase in AZD5069 concentration.